Oji Holdings announces that Oji Group's paper was adopted by Nestle in Malaysia as 3rd market for replacement of plastic package to paper package as a solution to reduce plastic for one of the biggest sustainability issues the world is facing today. We highly appreciate Nestle's considerate commitment towards creation of sustainable society. At the same time we will maintain supporting Nestle's action as a packaging material supplier. As environmental statements were made at G20 summit which was held in Osaka in June 2019, the need to replace plastic with paper for the purpose of environment protection is increasing all over the world. Oji Group would like to engage in SDGs by supply of environmental friendly products together with our clients' actions.
Aptar CSP Technologies, a leader in active material science solutions (part of AptarGroup, Inc.), announced that its proprietary Activ-Film™ technology was approved by the U.S. Food and Drug Administration (FDA) for use within a recently launched Rechargeable Implantable Neurostimulator (INS) that treats urinary and bowel dysfunction. The Activ-Film™ material is integrated into the medical device to control humidity, improve the accuracy of readings, and extend use life.
Aptar CSP’s Activ-Film™ material leverages the company’s patented 3-Phase Activ-Polymer™ platform technology to manage the device’s internal atmosphere, adsorbing moisture that could otherwise accumulate and affect the implant’s stability and performance. Controlling the humidity within the device protects the battery and enables it to have little to no degradation during its use life.
“This is another example of our consistent commitment to helping customers bring advanced solutions to patients and improve user experiences and outcomes,” said Badre Hammond, Vice President Commercial Operations, Aptar CSP Technologies. “We are dedicated to continued material science innovation that facilitates the development and commercialization of next generation implantable medical devices.”
Activ-Film™ material is a configuration of Aptar CSP’s 3-Phase Activ-Polymer™ technology. In addition to protecting a range of implantable medical devices, the highly-engineered technology is utilized in various formats for a broad array of applications, including oral solid dose drugs, drug delivery systems and probiotics. The material science technology can be customized to deliver integrated active solutions that adsorb moisture, scavenge oxygen, odor, or VOCs, emit aromas, or reduce pathogens.